Evaluating the potential health and economic impact of different vaccination strategies with the adult-specific 21-valent pneumococcal conjugate vaccine in adults aged ≥ 65 years in Japan
Year: 2026
Type: article
Abstract: BACKGROUND: We estimated the health and economic impact of adult pneumococcal vaccination strategies in Japan, comparing the adult-specific PCV21 (aPCV21) to PCV20. RESEARCH DESIGN AND METHODS: A published Markov model simulated the epidemiology of pneumococcal disease in Japanese adults aged ≥ 65 years over a lifetime horizon using single- and multi-cohort analyses. Outcomes included cases of invasive pneumococcal disease (IPD), non-bacteremic pneumococcal pneumonia (NBPP), disease-related deaths, and direct and indirect costs (2023 Japanese yen [¥]). The base case evaluated vaccination at age 65, while scenario analyses assessed expanded age-based (≥65) vaccination, coverage rates, duration of protection, and indirect protection. RESULTS: Compared to PCV20, aPCV21 prevented 35% more IPD outcomes (cases and deaths) and 33% more NBPP outcomes in the base case. Combined direct and indirect disease/death-related cost savings versus no vaccination increased from ¥3,983 million with PCV20 to ¥5,299 million with aPCV21. Expanding age-based vaccination from adults aged 65 to ≥65 years, prevented an additional 12% points of IPD outcomes and 6% points of NBPP outcomes. Across all scenario analyses, aPCV21 prevented ≥ 25% more cases and costs compared to PCV20. CONCLUSIONS: Based on scenario analyses, the use of aPCV21 in Japanese adults provides substantial health and economic benefits compared to PCV20.
Source: Expert Review of Vaccines
Authors: Peter P. Mueller(Conceptualization, Formal analysis, Investigation, Writing – original draft, Writing – review & editing), Atsushi Tajima(Conceptualization, Investigation, Writing – review & editing), Kelsie Cassell(Conceptualization, Investigation, Writing – review & editing), Taizo Matsuki(Conceptualization, Investigation, Writing – review & editing), Nicole Cossrow(Conceptualization, Investigation, Writing – review & editing), Zinan Yi(Conceptualization, Investigation, Writing – review & editing), Kelly D. Johnson(Conceptualization, Investigation, Writing – review & editing), Kwame Owusu-Edusei(Conceptualization, Investigation, Writing – review & editing)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7234951399
